Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease [Phase 1, Phase 2]
A multicenter study evaluating delayed-release 6-mercaptopurine for Crohn's disease (Phase 1/Phase 2) has been terminated.
-
CLINICAL_TRIALS withdrawal · 2013-03-07Clinical Trial Update: Open Label Extension Study to Protocol C2/13/DR-6MP-02 [Phase 2]
A Phase 2 open-label extension study (Protocol C2/13/DR-6MP-02) for Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-06Clinical Trial Update: Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease [Phase 4]
Phase 4 trial evaluating top-down therapy for pediatric Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS research · 2013-03-04Clinical Trial Update: The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry
This entry reports the completion of a Crohn's disease registry trial (The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Regist…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Evaluating rhIL-11 in Active Crohn's Disease [Phase 2]
Phase 2 trial of recombinant human interleukin-11 in active Crohn's disease has completed; Wyeth is now a subsidiary of Pfizer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care [Phase 2]
A Phase 2 trial evaluated telemedicine-based outpatient care for inflammatory bowel disease, including ulcerative colitis and Crohn's diseas…
-
FDA approval · 2013-01-25FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Post Marketing Surveillance of Remicade
The document reports the completion of a post-marketing surveillance study of Remicade (infliximab) in Korea assessing safety in Crohn's dis…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Remicade Infusion Management Program
This update reports completion of Janssen's Remicade infusion management program trial evaluating infliximab for Crohn's disease and rheumat…
-
FDA approval · 2013-01-14FDA Approved: BUDESONIDE — Original Application (Oceanside Pharmaceuticals)
FDA approved the original application for budesonide from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS research · 2013-01-11Clinical Trial Update: The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) [Phase 4]
Phase 4 clinical trial investigating whether probiotics affect exacerbations in Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease [Phase 2]
Pfizer completed a Phase 2 study evaluating the safety and efficacy of CP-690,550 (tofacitinib) in moderate to severe Crohn's disease, with …
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR [Phase 3]
Phase 3 trial FER-IBD-COR evaluating Ferinject (ferric carboxymaltose) for correcting iron-deficiency anemia in inflammatory bowel disease h…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease [Phase 3]
Phase 3 study evaluating topical 10% metronidazole ointment for active perianal Crohn's disease has completed (status: COMPLETED) according …
-
FDA approval · 2012-12-12FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine En-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD) [Phase 3]
Phase 3 trial evaluating higher-dose TA-650 (Infliximab) for Crohn's disease, reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Phase II Study of HMPL-004 in Subjects With Crohn's Disease [Phase 2]
A Phase II clinical trial of HMPL-004 in Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Optimizing Cimzia in Crohn's Patients [Phase 4]
Phase 4 clinical trial update evaluating certolizumab pegol (Cimzia) to optimize treatment in Crohn's disease.
-
CLINICAL_TRIALS withdrawal · 2012-10-30Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease [Phase 2]
A Phase II study of Olokizumab for Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Thalidomide in Pediatric Inflammatory Bowel Diseases. [Phase 3]
Phase 3 pediatric trial of thalidomide for inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, has completed.
-
FDA approval · 2012-09-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut [Phase 1, Phase 2]
A Phase 1/2 trial assessing the safety and tolerability of FITC-conjugated adalimumab administered during confocal laser endomicroscopy in C…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)
A post-marketing surveillance study of infliximab (Remicade) in chronic inflammatory diseases has completed, with results posted in 2012. Th…
-
CLINICAL_TRIALS withdrawal · 2012-08-31Clinical Trial Update: Chondroitin Sulfate for Crohn's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating chondroitin sulfate for Crohn's disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Single Ascending Dose Study of Oral CPSI-2364 (Semapimod) [Phase 1]
This update reports completion of a Phase 1 single ascending dose study of CPSI-2364 (semmapimod) in Crohn's disease.